Vimarsana
Biggest News Aggregation in the World

Mackenzie Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mackenzie Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mackenzie Partners Today - Breaking & Trending Today

Glass Lewis recommends Hess shareholders vote for proposed merger with Chevron - Vimarsana News

Glass Lewis recommends Hess shareholders vote for proposed merger with Chevron

Hess Corporation has announced that independent proxy voting and corporate governance advisory firm Glass Lewis has recommended that Hess shareholders vote FOR the proposed merger with Chevron.

Glass Lewis Recommends Hess Shareholders Vote For Proposed Merger With Chevron - Vimarsana News

Glass Lewis Recommends Hess Shareholders Vote For Proposed Merger With Chevron

Hess Corporation today announced that independent proxy voting and corporate governance advisory firm Glass, Lewis & Co. has recommended that Hess shareholders vote FOR the proposed merger with...

Mason Capital Announces Tender Offer for Any and All of (i) the Outstanding American Depositary Shares (the "ADSs"), each representing 4,000 Ordinary Shares, Nominal Value 0.01 DKK of Forward Pharma A/S (the "Ordinary Shares") for a Purchase Price of $437.00 per ADS and (ii) the Outstanding Ordinary Shares for a Purchase Price of 0.76 DKK per Ordinary Share - Vimarsana News

Mason Capital Announces Tender Offer for Any and All of (i) the Outstanding American Depositary Shares (the "ADSs"), each representing 4,000 Ordinary Shares, Nominal Value 0.01 DKK of Forward Pharma A/S (the "Ordinary Shares") for a Purchase Price of $437.00 per ADS and (ii) the Outstanding Ordinary Shares for a Purchase Price of 0.76 DKK per Ordinary Share

NEW YORK, May 14, 2024 /PRNewswire/ — Mason Capital Management LLC, a Delaware limited liability company (“Mason Capital”), announced today that it has commenced a tender offer (the “Tender Offer”) for any and all the outstanding ADSs and Ordinary Shares in Forward Pharma A/S (the “Company”) for a purchase price of $437.00 per ADS or […]

Leading Proxy Advisory Firm Glass Lewis Recommends That - Vimarsana News

Leading Proxy Advisory Firm Glass Lewis Recommends That

Glass Lewis Further Recommends That Shareholders Do Not Vote For Any EREZ Nominees...

GrafTech's Board of Directors Issues Open Letter to Stockholders -April 02, 2024 at 08:22 am EDT - Vimarsana News

GrafTech's Board of Directors Issues Open Letter to Stockholders -April 02, 2024 at 08:22 am EDT

GrafTech Files Definitive Proxy Materials for 2024 Annual Meetings of Stockholders GrafTech Stockholders Urged to Vote “FOR” the Board-Recommended Nominees Using WHITE Proxy Card ...